Late Breaking News Abstract Submission

Late Breaking News

The Scientific Committee welcomes the submission of Late Breaking Abstracts for presentation at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis which will take place 10-12 October in Berlin, Germany.

Late Breaking News abstracts, containing new information or important findings not (fully) available before the general abstract deadline, can be submitted until Wednesday, 25 July 2018, 23:59 CET.

Please note that the late-breaking abstract deadline is not an extension of the general abstract submission deadline.

Late Breaking News

The Scientific Committee welcomes the submission of Late Breaking News abstracts for presentation at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.

Late Breaking News abstracts, containing new information or important findings not (fully) available before the general abstract deadline, can be submitted until Wednesday, 25 July 2018, 23:59 CET.

Please note that the late-breaking abstract deadline is not an extension of the general abstract submission deadline.

In order to standardise the abstract layout, we kindly ask you to read the guidelines at this link carefully.

Guidelines for preparation of abstracts

Abstracts may only be submitted online. Abstracts submitted by fax or email will not be accepted.

Abstracts must be submitted in English. Please use UK English spelling.

The presenting author of an accepted abstract must register and attend the congress.

Poster presenters must be present and stand by their posters during their assigned poster sessions.

Abstracts should contain only original material not published or presented elsewhere prior to 10 October 2018.

Provide a short specific title indicating the nature of the investigation. The background and goals of the study should appear clearly to the reader. The methods and results must contain data, and the conclusions should be clearly expressed.

The title may not exceed 250 characters including spaces. The abstract text may not be longer than 2500 characters (ca. 300 words) including spaces, excluding disclosures.

All abbreviations must be defined the first time they appear in your text (but, do not define in the title). Example: Multiple Sclerosis Impact Scale (MSIS), before being used as an abbreviation only.

Use generic drug names.

Tables, charts or other graphics may not be included and will be deleted by the editors.

Authors should indicate their presentation type preference:

poster presentation only

oral or poster presentation

Note: "Poster presentation only" implies that your abstract will be considered for poster presentation only and will not be eligible for one of the poster prizes (see corresponding paragraph Prizes).

The Scientific Programme Committee reserves the right to decide on the final allocation and presentation method.

Kindly note that an author may only give a maximum of 1 oral presentation that have been selected through submitted abstracts. In case an author has more than 1 oral abstract presentations, the person will be contacted to discuss which abstract will be presented by the author and who will present the other presentation(s) from the list of co-authors. If none of the co-authors can present the abstract, the abstract will no longer be considered for oral presentation.

A selected number of abstracts will be accepted for oral presentation based on their scientific merits and on their relation to the topics addressed in the scientific programme of the Congress. We therefore encourage submissions on the main topics covered in the scientific programme.

Disclosure of potential conflict of interest (e.g. grant support, consultancy, membership on advisory councils, speaker’s bureau) by all authors and source of funding are mandatory. Each listed author should prepare a one sentence statement that will be published with the abstract. All disclosures should be listed within the last 3 year.

Abstracts from commercial entities will be considered. However, abstracts reporting results from collaborative research conducted by independent (non-company) investigators and investigators who are employees of commercial entities will not be accepted unless the independent (academic, clinician and/or scientist) investigators are included as authors.

Please make sure to state your correct e-mail address. After having submitted your abstract, you will receive a confirmation by e-mail with the following information:

reference number of your abstract (for correspondence and questions that might arise)

Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access code. This will shorten the submission procedure. Corrections to abstracts can only be made up to the deadline of 25 July 2018, 23:59h CEST.

We kindly ask you to upload a picture of the presenting author. Please prepare the photo in one of the following formats: JPG or GIF with a max. size of 1 MB.

Notification

Each abstract will be reviewed by at least 3 external experts and final selection will be made by the Scientific Programme Committee. Notification of acceptance or rejection of submitted abstracts will be sent to the corresponding authors via email in July 2018. Full instructions concerning preparation and presentation will be included.

Publication

All accepted abstracts (incl. Late Breaking News) will be published in the online supplement of the Multiple Sclerosis Journal as well as on the ECTRIMS Congress’s website, Mobile App and in the ECTRIMS Online Library.

Full text of regular abstracts will be published 14 days prior to the congress (26 September 2018) on the congress website. Late Breaking News will be published on the first day of the congress (10 October 2018).

Presentation available on the ECTRIMS website

Posters and PowerPoint-slides of accepted presentations will be posted on the ECTRIMS website after the congress. All authors will be asked to agree to the publication of their actual poster or oral PowerPoint-presentation.

If you do not agree, please click the appropriate checkbox during the online abstract submission.